Moran Wealth Management, LLC Abb Vie Inc. Transaction History

Moran Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $158,879 - $197,715	-1,199 Reduced 24.38%	3,718 $500,000
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $18.7 Million - $21.5 Million	-128,986 Reduced 96.33%	4,917 $783,000
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $18.5 Million - $22.2 Million	133,903 New	133,903 $0

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Moran Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moran Wealth Management, LLC with notifications on news.